Rivastigmine tartrate (Standard) | MedChemExpress (MCE)
Rivastigmine (tartrate) (Standard) is the analytical standard of Rivastigmine (tartrate). This product is intended for research and analytical applications. Rivastigmine tartrate (ENA 713; SDZ-ENA 713) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM, 4.15 μM, respectively. Rivastigmine tartrate can pass the blood brain barrier (BBB). Rivastigmine tartrate is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer’s type and dementia due to Parkinson’s disease[1][2].
| Trivial name | Rivastigmine tartrate (Standard) |
| Catalog Number | HY-11017R |
| Alternative Name(s) | ENA 713 (Standard); SDZ-ENA 713 (Standard) |
| Research Area | Neurological Disease |
| CAS# | 129101-54-8 |
| Purity | ≥98.0% |
| SMILES | O=C(OC1=CC=CC([C@@H](N(C)C)C)=C1)N(CC)C.O=C(O)[C@H](O)[C@@H](O)C(O)=O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/rivastigmine-tartrate-standard.html |